tiprankstipranks
Advertisement
Advertisement

Golden Throat Sets 2026 AGM to Approve Dividend, Auditor and Share Mandates

Story Highlights
  • Golden Throat has called a June 2026 AGM to adopt 2025 results and approve a HK$0.34 dividend.
  • Shareholders will vote on auditor reappointment and a fresh share issuance mandate, shaping funding flexibility.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Golden Throat Sets 2026 AGM to Approve Dividend, Auditor and Share Mandates

Meet Samuel – Your Personal Investing Prophet

Golden Throat Holdings Group Co Ltd ( (HK:6896) ) has shared an update.

Golden Throat Holdings Group Co Ltd has convened its annual general meeting for 5 June 2026 in Hong Kong, where shareholders will be asked to receive and adopt the audited consolidated financial statements for the year ended 31 December 2025 and approve a proposed final dividend of HK$0.34 per share. The meeting will also consider reappointing Ernst & Young as auditor, authorising the board to set directors’ and auditor’s remuneration, and granting directors a general mandate to issue new shares and deal with treasury shares within defined limits, a move that preserves the company’s capital-raising flexibility and could influence future funding and dilution for investors.

If approved, the dividend proposal signals management’s confidence in the company’s 2025 financial performance and provides direct cash returns to shareholders, while the reappointment of Ernst & Young supports continuity in financial oversight and reporting standards. The share issuance mandate, capped at a percentage of the existing share capital and excluding standard exceptions such as rights issues, share options, and scrip dividends, aligns with common Hong Kong market practice and is likely to be seen as routine but important for maintaining strategic financial optionality in response to market opportunities or operational needs.

More about Golden Throat Holdings Group Co Ltd

Golden Throat Holdings Group Co Ltd is a Cayman Islands-incorporated company listed in Hong Kong, operating in the consumer healthcare and pharmaceutical-related sector. The group is best known for its branded throat-care products, with its shares traded on the Main Board of the Stock Exchange of Hong Kong under stock code 6896, and it maintains a shareholder base that regularly acts on AGM mandates.

Average Trading Volume: 751,727

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$2.65B

See more data about 6896 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1